Skip to main content
. 2019 Jul 8;51(7):76. doi: 10.1038/s12276-019-0274-7

Table 2.

Serum alanine transaminase (ALT) and aspartate transaminase (AST) levels in the control, sorafenib, and apatinib groups (n = 4)

Group ALT (IU/l) AST (IU/l)
Control 47.75 ± 1.11 152.5 ± 11.81
Sorafenib 82.83 ± 19.25 210.3 ± 21.70
Apatinib 67.00 ± 7.10 200.7 ± 21.53